secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zomedica Corp. (ZOMDF)
CIK:        0001684144
Form:       8-K
Filed at:   2023-01-24T23:59:59+00:00
Accession:  0001654954-23-000712
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 1.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zomedica restructures TRUFORMA deal with Qorvo; takes control of development and manufacturing
--------------------------------------------------------------------------------

- ZomInc pays $4M up-front license fee and up to another $4M upon cartridge production line qualification.
- Option to extend exclusive TRUFORMA rights for veterinary use perpetually for $8M one-time fee.
- ZomInc to take over assay development and manufacturing at Roswell, GA facility over ~18 months.
- Prior Development Agreement terminated with no early termination penalties.
- Zomedica Corp guarantees all obligations of ZomInc under each agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1684144/000165495423000712/0001654954-23-000712-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1684144/000165495423000712/zom_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-000712

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer